|
Remember to add us to your contacts list to ensure you receive our emails
|
|
|
|
|
|
|
Hello and a very warm welcome to the EMJ Urologynewsletter. Inside you will find the most up-to-date scientific discoveries, exciting events, and breaking news that the field of urology has to offer. Among the featured events is the 33rd World Congress of Endourology and SWL, one of the world’s foremost meetings in endourology. This year the meeting will take place in the vibrant city of London, and its programme promises to be unmissable. Also included is a glimpse of the research that has resulted in the development of a new surgical technique, which preserves long-term normal kidney function following surgery for tumour removal. We hope that you enjoy reading this informative newsletter, and for more information and access to our previous eJournals visit our website.
Articles
Contemporary Role of Testis Sparing Surgery: A Systematic Review
GI Russo et al.
Testis-sparing surgery (TSS) represents a therapeutic choice for testicular cancer (TC). However, international guidelines are very cautious about the use of the testis-sparing technique, namely due to the lack of certain indications and long-term oncological outcomes. The aim of this systematic-review is to illustrate current trends of what may today be the uses of organ-sparing surgery in TC, to evaluate the relationship between the organ-sparing safety and oncological features such as definitive histology, tumour size, and post-surgery oncological outcomes. This analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines. An electronic search of the Medline and Embase was undertaken until September 2014. The search was limited to English-Language articles. Current indications of TSS are synchronous bilateral testicular tumours, metachronous contralateral tumours, or tumour in a solitary testis with normal preoperative testosterone levels. Moreover, histological characteristics should not be taken into account when performing a TSS approach. TSS outcomes for germ cell tumours are encouraging and we reported high rates of disease-free survival and a few cases of patients receiving neoadjuvant chemotherapy or radiotherapy. In light of the examined, TSS could be considered a viable alternative to radical surgery of the testis but it should be performed in specialised centres with competence.
UD Reddy et al.
Complicated urinary tract infection (UTI) has always been a challenging subject to diagnose and treat. New, less invasive, techniques have been introduced in the last decade with the development of the new generations of high definition endoscopes and the robotic platforms to treat the surgically correctable pathologies underlying UTIs. This review will discuss the different underlying pathological conditions for complicated UTI and their management.
“We found that robot-assisted radical cystectomy, an advanced surgical procedure used to treat bladder cancerthat has spread to the bladder wall or recurred, despite local treatment in the bladder, provides similar early oncological outcomes while reducing operative blood loss.”
New Surgical Method Preserves Kidney Function After Tumour Removal
“The new surgical technique allows renal function to be fully maintained, even though we can achieve the same oncological and surgical results as we do with clamping the organ.”
What’s Happening in EMJ: Urology
The 11th National Endourology Congress held in April in Antalya, Turkey, was a momentous event, and EMJ was there to report on all of the highlights. Our latest EMJ Urology eJournal provides a full account of the event and also features high quality manuscripts covering hot topics in the field, interviews from our esteemed editorial board, and much more. Additionally, feel free to connect with us through our social media platforms including Twitter, LinkedIn, and Facebook. We wish you the best of luck with the rest of your year and look forward to seeing you across Europe very soon.
|
|
Featuring a full review of Endourology 2015
Antalya, Turkey
|
|
|
|
|
|
|
_________________________________________________________
|
|
|
European Medical Journal
Head Office – The MedBIC, Anglia Ruskin University, Alan Cherry Drive, Chelmsford, Essex, CM1 1SQ
Sales Office – Coppergate House, 16 Brune Street, London, E1 7NJ
Switchboard: +44 (0) 1245 334450
Registration No: 08198092. The information contained in this message is confidential and maybe legally privileged. It is intended for the addressee(s) only. Any unauthorised use, dissemination of the information, or unauthorised copying/forwarding of this message is prohibited. If you are not the intended addressee, please notify the sender immediately by return email and delete this message. Any views expressed in this message are those of the individual sender, except where the message states otherwise and the sender is authorised to state them.
|
|
|
_________________________________________________________
|
|
|
|
|
To ensure that you continue receiving our emails, please add us to your address book or safe list. If you are receiving this email continuously and if you think this is SPAM, please report to circulation@emjreviews.com and we will try our best to resolve your concerns. If you would like to Subscribe to receive further updates from the European Medical Journal, please follow the link at the bottom through to our automated system, alternatively if you would like to Unsubscribe please also use the link provided.
|
|
|
|
|
|
|
_newsletter.jpg)
_newsletter.jpg)
.png)
